key: cord-0900073-mxhtn9nf authors: Umair, Massab; Ikram, Aamer; Salman, Muhammad; Haider, Syed Adnan; Badar, Nazish; Rehman, Zaira; Ammar, Muhammad; Rana, Muhammad Suleman; Ali, Qasim title: Genomic surveillance reveals the detection of SARS‐CoV‐2 delta, beta, and gamma VOCs during the third wave in Pakistan date: 2021-11-09 journal: J Med Virol DOI: 10.1002/jmv.27429 sha: 6fec47827fc000af76b04b288d369c6411dc3b0e doc_id: 900073 cord_uid: mxhtn9nf SARS‐CoV‐2 variants of concern (VOCs) have emerged worldwide and gained significant importance due to their high transmissibility and global spread, thus meriting close monitoring. In Pakistan, limited information is available on circulation of these variants as the alpha variant has been reported the main circulating lineage. The current study was designed to detect and explore the genomic diversity of SARS‐CoV‐2 lineages circulating during the third wave of the pandemic in the indigenous population. From May 01 to June 09, 2021, a total of 16 689 samples were tested using TaqPath™ COVID‐19 kit for the presence of SARS‐CoV‐2. Overall, 2562 samples (15.4%) were COVID‐19 positive. Out of these positive samples, 2124 (12.7%) did not show the spike gene amplification (spike gene target failure ([SGTF]), whereas 438 (2.6%) showed spike gene amplification (non‐SGTF). A subset (n = 58/438) of non‐SGTF samples were randomly selected for whole‐genome sequencing. Among VOCs, 45% (n = 26/58) were delta, 46% (n = 27/58) were beta, and one was gamma variant. The delta variant cases were reported mainly from Islamabad (n = 15; 58%) followed by Rawalpindi and Azad Kashmir (n = 1; 4% each). Beta variant cases originated mainly from Karachi (n = 8; 30%) and Islamabad (n = 11; 41%) and the gamma variant case was reported in a traveler from Italy. The delta, beta, and gamma variants possessed lineage‐specific spike mutations. Notably, two rare mutations (E484Q and L5F) were found in the delta variant. Furthermore, in the beta variant, two significant rare non‐synonymous spike mutations (A879S and K444R) were also reported. High prevalence of beta and delta variants in local population may increase the number of cases in the near future and provides an early warning to national health authorities to take timely decisions and devise suitable interventions to contain a possible fourth wave. The COVID-19 pandemic is still one of the leading cause of infectious mortality worldwide due to emergence of novel SARS-CoV-2 variants. As of July 31, 2021, the global total of SARS-CoV-2-related infections has surpassed over 198 million, with 4.22 million deaths. In recent months, a diversification of SARS-CoV-2 has been observed globally because of evolution and adaptation processes. Some emerging mutations may confer a selective advantage to the virus, resulting in the selection of the "variants of concern" (VOCs) with significant epidemiological and pathogenic consequences. 1 There is an evidence that strains with N501Y substitution have increased transmissibility due to enhanced binding affinity with human angiotensin-converting enzyme 2 (ACE2) as determined by deep mutation scanning in a mouse model. [5] [6] [7] Additionally, the beta and gamma variants may provide an immune escape mechanism from antibodies due to E484K mutation in the spike protein. 8 It has been recently identified that these variants are capable of evading monoclonal and serum antibody responses. 9, 10 The K417N/T, E484K, and N501Y mutations significantly decreased the neutralizing activity of convalescent and messenger RNA vaccine-induced serum. 11 The delta variant was first detected in Maharashtra, India in October, 2020. Its sub-lineage, B.1.617.1, is defined by the presence of a constellation of mutations, L452R, P681R, and E484Q in the spike region, whereas B.1.617.2 is characterized by following spike mutations: L452R, P681R, and T478K. The RBD mutations enhance infectivity due to the presence of L452R and T478K by increasing the spike protein's affinity for human ACE2 receptor. 12, 13 Both mutations reduce the binding affinity of monoclonal antibodies, thereby impairing neutralizing ability. Additionally, structural analysis of mutations (L452R and E484Q) in RBD and furin cleavage site (P681R) revealed increased ACE2 binding and cleavage rate resulting in increased transmissibility. 14 The delta variant has now spread to 112 countries, with a global cumulative prevalence of 12% (n = 267 594) with the most notable prevalence of 44% (n = 14 938) in India. The beta variant has been spread to 107 countries with a global cumulative prevalence of 1% (n = 29 843) and the highest prevalence of 61% (n = 6121) in South Africa. The gamma variant has spread to 65 countries, with a global cumulative prevalence of 2% (n = 55 587) and highly prevalent (n = 15 011, 62%) in Brazil (https://outbreak.info, accessed on July 31, 2021). The prevalence of these variants around the globe and in the originating countries gives a clue about the emergence of possible new outbreaks/waves throughout the world. As of July 31, 2021, there has been 1 029 811 positive cases of SARS-CoV-2 with 23 360 deaths in Pakistan. According to provincewise data, the maximum number of cases were reported in Sindh (n = 380 093), Punjab (n = 356 211), Khyber Pakhtunkhwa (n = 143 673) and Islamabad (n = 87 304). 15 In comparison to the number of reported cases. the genome sequencing data submitted to global SARS-CoV-2 databases (GISAID and NCBI) from Pakistan is very limited (n = 614), resulting in limited assessment of the introduction, geographic spread, and community transmission of SARS-CoV-2 variants. Hence, the current study aimed to detect and explore the genomic diversity of different lineages circulating in Pakistan during the third wave. Oropharyngeal samples (n = 16 689) were collected from COVID-19 suspected patients and received at the Department of Virology, National Institute of Health, Islamabad. RNA was extracted from the samples using a KingFisher™ Flex Purification System (Thermo Fisher Scientific). For the detection of SARS-CoV-2, TaqPath™ COVID-19 CE-IVD RT-PCR kit (Thermo Fisher Scientific) that targets three genes (ORF1ab, N, and S) was used. Previously, we had used the SGTF as a proxy for the detection of alpha variant in Pakistan using the TaqPath™ kit (Thermo Fisher Scientific). 13 This detection method can also be used the other way around for surveillance of other lineages. Based on this strategy, the non-SGTF samples having low cycle threshold (C t ) values (≤27) followed by selection based on their geographical location, that is, representing the whole country were selected for whole-genome sequencing. The cDNA synthesis and amplification were performed according to the Primal-Seq Nextera XT protocol (version 2) using SuperScript™ IV VILO™ Master Mix (Invitrogen) and Q5 ® High-Fidelity 2X Master Mix (New England BioLabs), with the ARTIC nCoV-2019 Panel V3 (Integrated DNA Technologies, Inc.). 16 The paired-end sequencing library ( The FastQC tool (v0.11.9) was used to assess the read quality of sequenced files. 16 Trimmomatic (v0.39) 17 was employed to remove Illumina adapter sequences and low-quality base calls with scores less than 30 to eliminate technical biases and artifacts. The filtered reads were assembled by aligning with the available reference genome of SARS-CoV-2 (Accession number: NC_045512.2) using the Burrows-Wheeler Aligner's (BWA, v0.7.17) with default settings. 18 Picard Tools was used to remove PCR duplicates from aligned reads (v2.25.4). 19 The variants were called and consensus sequences of all the genomes were generated as per Centers for Diseases Control and Prevention (CDC) guidelines. 20 The assembled genomes were classified into PANGO lineages using the Pangolin v3.1.7 and pangoLEARN model dated 28-07-2021. 21 Nextstrain's standard protocol for analyzing SARS-CoV-2 genomes was used for the phylogenetic analysis. To begin, BLAST search was conducted on the GISAID database against each of the current study's isolates (beta, gamma, and delta). This resulted in a total of 286 sequences including the current study's sequences. The sequences were clustered using Augur Nextstrain's phylodynamic pipeline. 22 Alignment of sequences to the Wuhan reference genome was performed using MAFFT v7.470. 23 The initial phylogenetic tree was constructed using IQTREE v1.6.12, 24 which utilizes generalized time-reversible (GTR) model to generate the tree. The bootstrapping was performed to ensure a high degree of confidence in tree topology. Using reference genome (GISAID ID: EPI_ISL_402125) the raw tree was rooted. TreeTime v0.8.1 was used to further process the tree to generate a time-resolved phylogeny based on maximum likelihood. 25 The resulting tree was visualized using Auspice. ranging from 20 to 53 years comprising 46% males and 42% females. The median age of patients infected with beta variant was 30 years ranging from 2 to 61 years. The female to male ratio was 1:1 with 48% of females and 48% of males. Table 2 The COVID-19 pandemic has affected every continent, resulting in a global health crisis that has been aggravated by emergence of dif- 30 and also have a role in increased transmissibility due to enhanced ACE2 binding based on the structural impact of these mutations in the furin cleavage site. 14 Moreover, in one female patient, a less prevalent spike mutation (about 0.5%), L5F was observed. This mutation in combination with D614G had demonstrated increased infectivity and enhanced transmissibility. 31 In case of beta variant, one of the patient is having a travel history of the Middle East carried two rare non-synonymous spike mutations, A27S and G181V, having a global prevalence of 5.7% and 0.1%, respectively according to GISAID data (July 31, 2021). Furthermore, in two patients a rare spike mutation (about 1%), A879S, was reported. This mutation along with D614G had been found to decrease the sensitivity of convalescent sera and thus more likely to evade immune responses. 31 In one of the sample, K444R mutation was observed that exhibit increased binding affinity to the human ACE2 receptor based on an in silico study. 32 These findings emphasize the critical nature of continuous monitoring of amino acid changes in the spike region for vaccine development and therapeutic antibodies. It is also critical to contain the variant spread and build national immunity through the vaccine rollout. Pakistan is currently lagging behind other countries in the global campaign for mass vaccination against COVID-19. As of July 31, 2021, only 6.31 million people are fully vaccinated that comprises 2.9% of the total population and 23.3 million people are partially vaccinated that comprises about 10.8% of the total population. 33 Currently, in Pakistan, mostly Chinese vaccines, that is, Sinopharm, Cansino Bio, and Sinovac are being administered. The efficacy of these vaccines against beta and delta variants has not been reported so far. In many countries, however, there is a growing concern regarding their efficacy against delta variants owing to recent worldwide outbreaks and vaccine breakthrough cases in fully vaccinated people. Indonesia recently reported the death of 131 health care workers who were mostly inoculated with Sinovac. 34 This raises the serious question of whether the vaccines used in the nationwide campaign can contain any future upsurge of COVID-19 cases due to the emergence of immuneevading variants. To address this concern, several countries have announced the use of other vaccines for booster doses. Though conclusive evidence supporting the need for so-called "booster" shots has yet to emerge, the health officials from Thailand to Bahrain and the United Arab Emirates have announced that they will offer the additional doses to some people already immunized with vaccines manufactured by Chinese manufacturers and AstraZeneca. 35 Such booster doses will also be a challenge for developing countries like Pakistan where vaccination rate is already very low and the priority is to vaccinate the vulnerable/susceptible population first. Pakistan has confronted a 4-month-long (March-June 2021) third wave of COVID-19 with the highest positivity rate reaching 11.6% in April, then declined to 2.35% in June and had recently started to rise again to 7.73% as of July 31, 2021, showing early signs of possible fourth wave. 36 In conclusion, the high prevalence of beta and delta variants reported in our study coupled with limited sequencing capacity (less than 1% of the total reported cases), lower vaccination rates against COVID-19, less efficient screening and quarantine protocols of inbound travelers, and ease in lockdown restrictions, that is, the opening of restaurants, tourism sector, educational institutes, outdoor marriage ceremonies starting from May 24, 2021, 37 suggests a possible increase in the number of cases in the near future and provides an early warning to national health authorities to take timely decisions and devise suitable interventions to contain the possible fourth wave. All the sequences generated in the current study are submitted to the GISAID under the accession numbers: EPI_ISL_2894980, EPI Nazish Badar COVID-19 Evolution During the Pandemic-Implications of New SARS-CoV-2 Variants on Disease Control and Public Health Policies Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection WHO. Tracking SARS-CoV-2 variants. Accessed Molecular dynamic simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the combination of E484K, K417N and N501Y mutations (501Y. V2 variant) induces conformational change greater than N501Y mutant alone, potentially resulting in an escape mutant The N501Y spike substitution enhances SARS-CoV-2 transmission Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy SARS-CoV-2 501Y. V2 escapes neutralization by South African COVID-19 donor plasma Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016 SARS-CoV-2 RBD in vitro evolution follows contagious mutation spread, yet generates an able infection inhibitor Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra COVID-19 Pakistan Cases. Government of Pakistan nCoV-2019 sequencing protocol v2 (GunIt) V. 2. Protocols. io; 2020 FastQC: a quality control tool for high throughput sequence data Fast and accurate long-read alignment with Burrows-Wheeler transform Picard tools Rapid, sensitive, full-genome sequencing of severe acute respiratory syndrome coronavirus 2 Pangolin: lineage assignment in an emerging pandemic as an epidemiological tool Augur: a bioinformatics toolkit for phylogenetic analyses of human pathogens MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform IQ-TREE: a fast and effective stochastic algorithm for estimating maximumlikelihood phylogenies TreeTime: maximum-likelihood phylodynamic analysis Importation of SARS-CoV-2 variant B. 1.1. 7 in Pakistan Proliferation of SARS-CoV-2 B. 1.1. 7 variant in Pakistan-a short surveillance account and the Center for Viral Systems Biology. outbreak.info; 2021. Accessed 22 COVID: the beta variant is surging in mainland Europe-should the UK be worried?; 2021. Accessed Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: a randomized clinical trial The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity Mutations in the SARS-CoV-2 spike protein modulate the virus affinity to the human ACE2 receptor, an in silico analysis COVID infections imperil Indonesia's vaccinated health workers, and hospitals COVID vaccine plans tweaked around the world in attempt to boost effectiveness against Delta variant NCOC allows staggered reopening of educational institutes, outdoor dining from The authors declare that there are no conflict of interests.